Literature DB >> 31460799

Comparison of Quality of Life and Nutritional Status of Between Roux-en-Y and Billroth-I Reconstruction After Distal Gastrectomy: A Systematic Review and Meta-Analysis.

Nannan Du1, Manman Chen2, Zefeng Shen1, Shengnan Li1, Ping Chen3, Parishit A Khadaroo4, Danyi Mao5, Lihu Gu3.   

Abstract

Background: This paper purports to use a meta-analysis to compare the postoperative quality of life (QoL) and nutritional status of between Roux-en-Y (R-Y) and Billroth-I (B-I) reconstruction after distal gastrectomy.
Methods: For this study, the following databases were searched for articles published from inception until December 2018: PubMed, Web of Science, EBSCO, and Cochrane library.
Results: A total of 13 eligible studies, covering 3645 patients, were selected for a meta-analysis. The analysis showed that compared with B-I group in term of short-term outcomes, patients undergoing R-Y reconstruction did not only have significantly better physiological function (P = 0.02), but had significantly less pain (P = 0.04). In the long-term outcomes, the dyspnea and constipation in the B-I group were worse than that in the R-Y group (P = 0.004; P = 0.04, respectively). Patients in the B-I group had higher cholesterol than those in the R-Y group at 5 years postoperatively (P = 0.003). There were no significant differences in termof other nutritional indicators including total protein, cholesterol, albumin, hemoglobin and weight in short-term outcomes.Conclusions: The final conclusion was that R-Y may be superior to the B-I reconstruction in some aspects of QoL. Besides, R-Y reconstruction could reduce the patient's cholesterol level for a long time. For the short-term outcomes, there were no significant differences in other common nutritional indicators.

Entities:  

Mesh:

Year:  2019        PMID: 31460799     DOI: 10.1080/01635581.2019.1656262

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  6 in total

Review 1.  [Reconstruction and functional results after gastric resection].

Authors:  W Schröder; H Fuchs; J Straatman; B Babic
Journal:  Chirurgie (Heidelb)       Date:  2022-08-29

Review 2.  The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis.

Authors:  Yingzhu Yang; Nannan Du; Laidi Xie; Jing Jiang; Jiahang Mo; Jiaze Hong; Danyi Mao; Derry Minyao Ng; Huiwei Shi
Journal:  World J Surg Oncol       Date:  2020-07-04       Impact factor: 2.754

3.  Does Low-Magnitude High-Frequency Vibration (LMHFV) Worth for Clinical Trial on Dental Implant? A Systematic Review and Meta-Analysis on Animal Studies.

Authors:  Xinjian Ye; Ying Gu; Yijing Bai; Siqi Xia; Yujia Zhang; Yuwei Lou; Yuchi Zhu; Yuwei Dai; James Kit-Hon Tsoi; Shuhua Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-04-27

4.  Health-Related Quality of Life in Patients With Locally Advanced Gastric Cancer Undergoing Perioperative or Postoperative Adjuvant S-1 Plus Oxaliplatin With D2 Gastrectomy: A Propensity Score-Matched Cohort Study.

Authors:  Jianhong Yu; Zaozao Wang; Zhexuan Li; Ying Liu; Yingcong Fan; Jiabo Di; Ming Cui; Jiadi Xing; Chenghai Zhang; Hong Yang; Zhendan Yao; Nan Zhang; Lei Chen; Maoxing Liu; Kai Xu; Fei Tan; Pin Gao; Xiangqian Su
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

5.  The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials.

Authors:  Feifei Zhou; Nannan Du; Lulin Zhou; Chenxi Wang; He Ren; Qiang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-26       Impact factor: 6.055

Review 6.  The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis.

Authors:  Beilei Zhang; Fengyan Zhou; Jiaze Hong; Derry Minyao Ng; Tong Yang; Xinyu Zhou; Jieyin Jin; Feifei Zhou; Ping Chen; Yunbao Xu
Journal:  World J Surg Oncol       Date:  2021-06-21       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.